Today: 9 June 2026
Browse Category

NYSE:BSX 22 October 2025 - 15 January 2026

Penumbra stock pops after Boston Scientific’s $14.5 billion buyout — what PEN investors watch next

Penumbra stock pops after Boston Scientific’s $14.5 billion buyout — what PEN investors watch next

Penumbra shares jumped 11.8% to $350.49 in after-hours trading Thursday after Boston Scientific announced a $14.5 billion cash-and-stock acquisition valuing Penumbra at $374 per share. The deal requires Penumbra shareholder approval and antitrust clearance. Penumbra posted preliminary Q4 revenue growth of over 21% year-over-year. Traders focused on the deal spread and closing risks.
15 January 2026
··
Boston Scientific’s $14.5B Penumbra buy: $374-a-share deal lifts PEN stock before the open

Boston Scientific’s $14.5B Penumbra buy: $374-a-share deal lifts PEN stock before the open

Boston Scientific will acquire Penumbra for about $14.5 billion, offering $374 per share in cash and stock. Penumbra shares rose more than 13% premarket, with the bid representing a 19.3% premium to the previous close. The deal expands Boston Scientific’s reach in catheter-based clot removal and neurovascular devices. Penumbra CEO Adam Elsesser will join Boston Scientific’s board.
15 January 2026
··
Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target as Valuation Debate Intensifies on Dec. 19, 2025

Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target as Valuation Debate Intensifies on Dec. 19, 2025

Boston Scientific shares traded at $95.76, down 0.36% as of 17:30 UTC Friday, after opening at $96.85 and moving between $95.64 and $97.24. The session coincided with December options expiration, with $7.1 trillion in contracts set to expire. UBS reiterated a Buy rating and $140 target, while Truist cut its target to $120. Trading volume Thursday reached 15.6 million shares, well above the 50-day average.
19 December 2025
·
Boston Scientific (BSX) Stock After Hours Dec. 18, 2025: Analyst Targets Shift, Options Point to Key Levels, and What to Watch Before Friday’s Open

Boston Scientific (BSX) Stock After Hours Dec. 18, 2025: Analyst Targets Shift, Options Point to Key Levels, and What to Watch Before Friday’s Open

Boston Scientific closed Thursday at $96.11, up 1.73%, with trading volume of 15.6 million shares, well above its 50-day average. After-hours trading was steady, with shares at $96.18 as of 6 p.m. ET. Truist Securities lowered its price target to $120 from $130 but kept a Buy rating. The stock remains 12.23% below its 52-week high of $109.50.
19 December 2025
·
Boston Scientific (BSX) Stock After Hours on Dec. 17, 2025: Analysts Stay Bullish as Shares Close Higher — What to Watch Before Thursday’s Open

Boston Scientific (BSX) Stock After Hours on Dec. 17, 2025: Analysts Stay Bullish as Shares Close Higher — What to Watch Before Thursday’s Open

Boston Scientific shares closed up 1.65% at $94.48 on Wednesday, outperforming the broader market as the S&P 500 fell 1.16%. The stock traded as high as $95.99 intraday and saw volume above its 50-day average. After-hours, BSX edged up to $94.70. The stock remains about 13.7% below its 52-week high set in September.
18 December 2025
·
Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target, RBC Raises to $130 as 2026 Catalysts Come Into Focus

Boston Scientific (BSX) Stock News Today: UBS Reiterates $140 Target, RBC Raises to $130 as 2026 Catalysts Come Into Focus

UBS reiterated a Buy rating on Boston Scientific, keeping its $140 price target and citing upside potential into 2026. RBC raised its target to $130, while Canaccord Genuity adjusted to $131. BSX shares opened near $92.93, down about 10% in a month, with a market cap around $138 billion. Analysts point to growth in cardiac devices but warn on valuation and policy risks.
17 December 2025
·
Boston Scientific (BSX) Stock on December 10, 2025: Why Shares Are Sliding While the Growth Story Stays Intact

Boston Scientific (BSX) Stock on December 10, 2025: Why Shares Are Sliding While the Growth Story Stays Intact

Boston Scientific shares closed at $92.53 on December 9, down 1.4% and marking a seventh straight decline, with trading volume spiking to 12.7 million shares. The stock sits about 15% below its September high despite strong Q3 results, including 20% year-over-year sales growth and adjusted EPS of $0.75, beating forecasts. Over the past year, BSX remains slightly positive and is up about 170% over five years.
10 December 2025
··
Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets

Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets

Boston Scientific (BSX) closed at $98.57 on December 3, down slightly, with shares trading in a $97.60–$99.30 range. EVP Arthur Butcher sold 17,313 shares on December 1 for about $1.76 million under a pre-arranged plan. The stock is up roughly 8–9% over the past year but remains about 9.6% below its September high. The company also received new European device approvals this week.
4 December 2025
·
Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific (BSX) Stock Today: Price Slips as Neuromodulation Bull Case, Epic EHR Deal and Big Fund Moves Shape the Outlook – November 19, 2025

Boston Scientific shares fell 2.6% to $96.60 in late trading Wednesday, extending a three-day slide despite new research highlighting neuromodulation growth and recent acquisitions. The stock remains in the upper half of its 52-week range, with a market cap near $145–150 billion and trading at about 53 times trailing earnings.
19 November 2025
Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

U.S. stock indexes hover near record highs after the Dow gained 0.5% Tuesday, while the Nasdaq slipped 0.2% on tech earnings misses. About 85% of S&P 500 companies have beaten forecasts, the highest rate in four years. AMD surged to record highs on AI chip deals, while Eli Lilly hit $935 on obesity drug demand. Netflix fell 6–7% pre-market after an earnings miss; Texas Instruments dropped nearly 9% on weak guidance.
22 October 2025
···········
1 2

Stock Market Today

  • Dollar General's Q1 Same-Store Sales Signal Growth Potential
    June 9, 2026, 1:55 PM EDT. Dollar General reported a 2% increase in first-quarter same-store sales, driven primarily by a 1.4% rise in customer traffic and 0.5% increase in average transaction value. This traffic-led growth suggests more frequent customer visits rather than price hikes. All merchandise categories posted positive comparable sales for a fifth consecutive quarter, with non-consumables outperforming consumables. Despite early quarter weather disruptions, the company saw consistent sales through March and early May, reaffirming its 2026 forecast of 2.2%-2.7% same-store sales growth. Dollar General's valuation appears modest, trading with a forward price-to-earnings ratio of 14.19 against an industry median of 31.30, though shares have fallen nearly 27% over three months. The retailer's value proposition continues to attract repeat visits amid competition from Walmart and Target, which posted higher comparable sales growth in recent quarters.

Latest articles

AHMA Shares Jump Over 100% With Little News Out

AHMA Shares Jump Over 100% With Little News Out

9 June 2026
Ambitions Enterprise Management Co. L.L.C shares soared 185% to $3.08 on Nasdaq with over 60 million shares traded, despite no new company news since April 30; the surge outpaced travel peers and left the price below its $4 IPO, with the company warning in its annual report of potential volatility, competition, seasonal risks, and a $5 million capital need.
Rigetti Drops 14% With Quantum Names Hit in Tech Selloff

Rigetti Drops 14% With Quantum Names Hit in Tech Selloff

9 June 2026
Rigetti shares plunged 14.4% to $18.64, erasing gains from bullish Bernstein commentary, as investors dumped high-growth tech stocks sector-wide despite analyst optimism on quantum computing’s future; the drop followed a director’s proposed stock sale and comes as Rigetti awaits finalization of a potential $100 million federal award.
Archer Aviation Drops After Cathie Wood Selloff; What Traders Are Tracking

Archer Aviation Drops After Cathie Wood Selloff; What Traders Are Tracking

9 June 2026
Archer Aviation plunged 9.1% to $5.21 after ARK Invest dumped over 2.2 million shares worth $12.7 million, intensifying pressure as investors fled speculative growth stocks; with FAA certification still pending and heavy cash burn, Archer’s stock remains vulnerable to further selloffs if milestones slip.
Aurora Shares Fall as Uber Pulls Back, Tech Stocks Struggle

Aurora Shares Fall as Uber Pulls Back, Tech Stocks Struggle

9 June 2026
Aurora shares dropped 3.5% to $6.04 as tech and autonomous-driving stocks slid, with Uber’s recent block sale of 67.5 million shares at $7.10 still weighing on sentiment; Aurora reported a Q1 net loss of $223 million on $1 million revenue, expects continued losses, and may need to raise more capital to support its commercial ramp.
Go toTop